Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Share-based Compensation (2019 - 2026)

Clene (CLNN) posted Share-based Compensation of $3.5 million for Q2 2026, up 153.4% on a QoQ basis from $1.4 million in Q4 2025, and up 49.56% year-over-year from $2.3 million in Q2 2025.

Analysis

Clene (CLNN) Share-based Compensation (2019 - 2026) Analysis & Trends

Clene has reported Share-based Compensation for 8 years, with the latest figure at $3.5 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 49.56% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 49.56% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, down 19.75% from the prior year.
  • Share-based Compensation was $3.5 million for Q2 2026 at Clene, up from $1.4 million in the prior quarter.
  • The five-year high for Share-based Compensation was $22.0 million in Q1 2024, with the low at $1.4 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $8.2 million, with a median of $2.7 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Share-based Compensation jumped 76.75% in 2023, then plunged 90.81% in 2024.
  • Over 5 years, Share-based Compensation stood at $2.0 million in 2022, then increased by 0.89% to $2.0 million in 2023, then declined by 12.02% to $1.8 million in 2024, then fell by 24.21% to $1.4 million in 2025, then soared by 153.4% to $3.5 million in 2026.
  • The last three Share-based Compensation figures came in at $3.5 million (Q2 2026), $1.4 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -950.00 Mn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 166.00 Mn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 249.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - 277.20 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 67.26 Mn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 19.00 Mn
10 Clene 45.69 Mn 45.69 Mn 54,000.00 3.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.46 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 2.68 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 2.26 Mn
Dec 31, 2024 1.80 Mn
Sep 30, 2024 2.19 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 21.99 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 21.52 Mn
Jun 30, 2023 21.23 Mn
Mar 31, 2023 16.21 Mn
Dec 31, 2022 2.03 Mn
Sep 30, 2022 12.17 Mn
Jun 30, 2022 12.07 Mn
Mar 31, 2022 11.94 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 9.06 Mn
Jun 30, 2021 9.13 Mn